Definium Therapeutics (DFTX) Intangibles (2020 - 2023)

Definium Therapeutics (DFTX) has 4 years of Intangibles data on file, last reported at $527000.0 in Q4 2023.

• Quarterly Intangibles fell 85.71% year-over-year to $527000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $527000.0 (down 85.71% YoY) and the FY2023 annual result came in at $527000.0, down 85.71% from the prior year.
• Intangibles fell to $527000.0 in Q4 2023 per DFTX's latest filing, from $1.3 million in the prior quarter.
• Across five years, Intangibles topped out at $28.5 million in Q1 2020 and bottomed at $527000.0 in Q4 2023.
• The 4-year median for Intangibles is $4.7 million (2020), against an average of $8.7 million.
• The widest annual swing landed in 2021, when Intangibles soared 46.93%; it then slumped 85.71% in 2023.
• Tracing DFTX's Intangibles over 4 years: stood at $4.7 million in 2020, then jumped by 46.93% to $6.9 million in 2021, then tumbled by 46.29% to $3.7 million in 2022, then slumped by 85.71% to $527000.0 in 2023.
• Per Business Quant, the three latest DFTX Intangibles figures stand at $527000.0 (Q4 2023), $1.3 million (Q3 2023), and $2.1 million (Q2 2023).

Peer Comparison